2019-05-09 10:28:00 Thu ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
President Trump ramps up 25% tariffs on $200 billion Chinese imports soon after China backtracks on the Sino-American trade agreement. U.S. trade envoy Robert Lighthizer and Treasury Secretary Steven Mnuchin express frustration that China attempts to renege on prior commitments to the key bilateral resolution of perennial issues from bilateral trade deficit balance and currency manipulation to intellectual property theft and arbitrary technology transfer. Trump warns that he may impose 25% tariffs on another $325 billion Chinese imports if both sides cannot agree on a major trade deal in the next few weeks.
As the Sino-U.S. top trade negotiators continue to engage in bilateral discussions, stock market investors face dark clouds of uncertainty around whether both sides can salvage a fair trade deal. Most major stock market indices from S&P 500, Dow Jones, and Nasdaq to Shanghai, Shenzhen, and Hong Kong experience 3.5% to 6.5% hefty losses and plunges in response to the current trade standoff between China and America. As President Trump accuses China of breaking the trade deal across 7 chapters of the 150-page draft agreement, Chinese Vice Premier Liu He expresses his sincere hope that both sides can resolve contractual differences in the yearlong trade war.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2018-04-17 12:38:00 Tuesday ET
Value investment strategies make investors wiser like water with core fundamental factor analysis. Value investors tend to buy stocks below their intrinsic
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-05-30 16:44:00 Thursday ET
AYA Analytica finbuzz podcast channel on YouTube May 2019 In this podcast, we discuss several topical issues as of May 2019: (1) Our proprietary alp
2019-03-17 14:35:00 Sunday ET
U.S. trade rep Robert Lighthizer proposes America to require regular touchpoints to ensure Sino-U.S. trade deal enforcement. America has to maintain the thr
2018-08-09 16:36:00 Thursday ET
President Trump applies an increasingly bellicose stance toward the Iranian leader Hassan Rouhani as he rejects a global agreement to curb Iran's nuclea
2017-11-29 07:42:00 Wednesday ET
The octogenarian billionaire and activist investor Carl Icahn mulls over steps to shake up the board of SandRidge Energy after the oil-and-gas company adopt